Legend Biotech (LEGN) Enterprise Value (QoQ) (2019 - 2025)
Legend Biotech (LEGN) Enterprise Value (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -223.39% |
| Sep 30, 2025 | -4.62% |
| Jun 30, 2025 | 39.65% |
| Mar 31, 2025 | -54.06% |
| Dec 31, 2024 | 7.36% |
| Sep 30, 2024 | -510.49% |
| Jun 30, 2024 | 95.16% |
| Mar 31, 2024 | 18.02% |
| Dec 31, 2023 | -11.23% |
| Sep 30, 2023 | 19.01% |
| Jun 30, 2023 | -67.78% |
| Mar 31, 2023 | 12.96% |
| Dec 31, 2022 | -48.86% |
| Sep 30, 2022 | -133.31% |
| Jun 30, 2022 | -0.72% |
| Mar 31, 2022 | 59.68% |
| Dec 31, 2021 | -77.39% |
| Sep 30, 2021 | 20.45% |
| Jun 30, 2021 | -18.41% |
| Mar 31, 2021 | 4.78% |